| Wednesday 4 September | |
| Oxford Biomedica | Half Year Results |
| Dunelm Group | Full Year Results |
| Just Group | Half Year Results |
| Secure Income REIT | Half Year Results |
| Frontier Developments | Full Year Results |
| Barratt Developments | Full Year Results |
| Halfords Group | Q1 Results |
| IQE | Half Year Results |
| Fuller, Smith & Turner | Trading Statement |
| Thursday 5 September | |
| PPHE Hotels | Half Year Results |
| Mpact | Half Year Results |
| Alumasc | Full Year Results |
| McBride | Full Year Results |
| Go-Ahead Group | Full Year Results |
| Genus | Full Year Results |
| Melrose Industries | Half Year Results |
| Dixons Carphone | Q1 Results |
| Beeks Financial | Full Year Results |
| Curtis Banks | Half Year Results |
| Gem Diamonds | Half Year Results |
| Redrow | Full Year Results |
| HSS Hire | Half Year Results |
| Redde | Full Year Results |
| Friday 6 September | |
| SIG | Half Year Results |
| Ashmore Group | Full Year Results |
| International Public Partnerships | Half Year Results |
| Berkeley Group | Trading Statement |
| Pacific Horizon Investment Trust | Full Year Results |
| Monday 9 September | |
| Associated British Foods | Trading Statement |
| S4 Capital | Half Year Results |
| Luceco | Half Year Results |
| Abcam | Full Year Results |
| HgCapital Trust | Half Year Results |
| Filta Group | Half Year Results |
| Tuesday 10 September | |
| Gulf Keystone | Half Year Results |
| TP Group | Half Year Results |
| Harworth Group | Half Year Results |
| Team 17 Group | Half Year Results |
| SimplyBiz | Half Year Results |
| Concurrent Technologies | Half Year Results |
| Trinty Exploration | Half Year Results |
| 888 Holdings | Half Year Results |
| Midwich Group | Half Year Results |
| JD Sports Fashion | Half Year Results |
| Hilton Food | Half Year Results |
| Ashtead Group | Q1 Results |
| Sanne Group | Half Year Results |
| Boku | Half Year Results |
| Nucleus Financial Group | Half Year Results |
| EKF Diagnostics | Half Year Results |
| Vectura | Half Year Results |
| Cairn Energy | Half Year Results |
| Bakkavor | Half Year Results |
| Bovis Homes | Half Year Results |
| IP Group | Half Year Results |
| Good Energy | Half Year Results |
| Litigation Capital | Full Year Results |
26 Nov 2018 09:05
Vectura Discontinues VR375 As Phase Three Study Misses Endpoints
LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a
Read more